Evidence map›Paper›PMID 33651911›Full record

ArticleHaemophilia : the official journal of the World Federation of Hemophilia2021

Vaccination against COVID-19: Rationale, modalities and precautions for patients with haemophilia and other inherited bleeding disorders.

Radoslaw Kaczmarek, Magdy El Ekiaby, Daniel P Hart, Cedric Hermans, Mike Makris, Declan Noone, Brian O'Mahony, David Page, Flora Peyvandi, Steven W Pipe and 7 more

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Haemophilia : the official journal of the World Federation of Hemophilia, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Safety of intramuscular COVID-19 vaccination in patients with haemophilia.Haemophilia : the official journal of the World Federation of Hemophilia · 2022
    Observational
  3. Innate immune suppression by SARS-CoV-2 mRNA vaccinations: The role of G-quadruplexes, exosomes, and MicroRNAs.Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 7 institutions in 9 countries.

Radoslaw KaczmarekCoagulation Product Safety, Supply and Access Committee, World Federation of Hemophilia, Montreal, Quebec, Canada.ORCID https://orcid.org/0000-0001-8084-1958
Magdy El EkiabyCoagulation Product Safety, Supply and Access Committee, World Federation of Hemophilia, Montreal, Quebec, Canada.
Daniel P HartCoagulation Product Safety, Supply and Access Committee, World Federation of Hemophilia, Montreal, Quebec, Canada.
Cedric HermansCoagulation Product Safety, Supply and Access Committee, World Federation of Hemophilia, Montreal, Quebec, Canada.
Mike MakrisCoagulation Product Safety, Supply and Access Committee, World Federation of Hemophilia, Montreal, Quebec, Canada.ORCID https://orcid.org/0000-0001-7622-7939
Declan NooneCoagulation Product Safety, Supply and Access Committee, World Federation of Hemophilia, Montreal, Quebec, Canada.
Brian O'MahonyCoagulation Product Safety, Supply and Access Committee, World Federation of Hemophilia, Montreal, Quebec, Canada.ORCID https://orcid.org/0000-0002-1530-0167
David PageCoagulation Product Safety, Supply and Access Committee, World Federation of Hemophilia, Montreal, Quebec, Canada.ORCID https://orcid.org/0000-0001-5009-260X
Flora PeyvandiCoagulation Product Safety, Supply and Access Committee, World Federation of Hemophilia, Montreal, Quebec, Canada.ORCID https://orcid.org/0000-0001-7423-9864
Steven W PipeCoagulation Product Safety, Supply and Access Committee, World Federation of Hemophilia, Montreal, Quebec, Canada.ORCID https://orcid.org/0000-0003-2558-2089
Thomas SanniéCoagulation Product Safety, Supply and Access Committee, World Federation of Hemophilia, Montreal, Quebec, Canada.ORCID https://orcid.org/0000-0002-9220-1840
Uwe SchlenkrichCoagulation Product Safety, Supply and Access Committee, World Federation of Hemophilia, Montreal, Quebec, Canada.
Mark W SkinnerCoagulation Product Safety, Supply and Access Committee, World Federation of Hemophilia, Montreal, Quebec, Canada.ORCID https://orcid.org/0000-0002-0934-0680
Alok SrivastavaCoagulation Product Safety, Supply and Access Committee, World Federation of Hemophilia, Montreal, Quebec, Canada.ORCID https://orcid.org/0000-0001-5032-5020
Amanda BokEuropean Haemophilia Consortium, Brussels, Belgium.
Glenn F PierceCoagulation Product Safety, Supply and Access Committee, World Federation of Hemophilia, Montreal, Quebec, Canada.ORCID https://orcid.org/0000-0002-3310-328X
World Federation of Hemophilia (WFH), European Association for Haemophilia, Allied Disorders (EAHAD), European Haemophilia Consortium (EHC), U.S. National Hemophilia Foundation (NHF)
Canadian Hemophilia Society · CAChristian Medical College, Vellore · INCliniques Universitaires Saint-Luc · BEQueen Mary University of London · GBTrinity College Dublin · IEUniversity of Michigan · USUniversity of Milan · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Blood Coagulation Disorders, InheritedHemophilia ACOVID-19COVID-19 VaccinesHumansPublic HealthVaccinationCOVID-19 Vaccines

Identifiers

PMID33651911
PMCPMC8014441
OpenAlexW3134324453

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.